Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

LY 544344

Known as: LY-544344, LY544344 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Metabotropic glutamate2/3 receptor agonism facilitates autonomic recovery after pharmacological panic challenge in healthy humans
Group II metabotropic glutamate receptors (mGluR2/3) are suggested to modulate anxiety, arousal, and stress including autonomic… 
Review
2012
Review
2012
New perspectives in glutamate and anxiety
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 2
Review
2010
Review
2010
Metabotropic Glutamate Receptors: Potential Drug Targets for Psychiatric Disorders
Metabotropic glutamate receptors (mGlu receptors) have emerged as new therapeutic targets for psychiatric disorders, such as… 
  • table 1
  • table 2
2010
2010
The intestinal absorption of a prodrug of the mGlu2/3 receptor agonist LY354740 is mediated by PEPT1: in situ rat intestinal perfusion studies.
LY354740 is a potent mGlu2/3 agonist with a limited oral bioavailability. Its alanyl prodrug, LY544344, showed high affinity to… 
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
2009
2009
Transepithelial Transport of the Group II Metabotropic Glutamate 2/3 Receptor Agonist (1S,2S,5R,6S)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY354740) and Its Prodrug (1S,2S,5R,6S)-2-[(2′S)-(2…
The limited oral bioavailability of the potent and selective group II metabotropic glutamate (mGlu) 2/3 receptor agonist, (1S,2S… 
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Highly Cited
2008
Highly Cited
2008
Efficacy and Tolerability of an mGlu2/3 Agonist in the Treatment of Generalized Anxiety Disorder
LY354740, a potent and selective mGlu (metabotropic glutamate receptor)2/3 agonist, has shown efficacy in the treatment of… 
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
2007
2007
Pharmacokinetics, Metabolism, and Excretion of the Intestinal Peptide Transporter 1 (SLC15A1)-Targeted Prodrug (1S,2S,5R,6S)-2-[(2′S)-(2-Amino)propionyl]aminobicyclo[3.1.0.]hexen-2,6-dicarboxylic…
The peptidyl prodrug (1S,2S,5R,6S)-2-[(2′S)-(2-Amino)propionyl]a-minobicyclo[3.1.0.]hexen-2,6-dicarboxylic acid, also known as… 
  • figure 2
  • figure 1
  • table 1
  • table 2
  • figure 3
Highly Cited
2006
Highly Cited
2006
Improved Bioavailability of the mGlu2/3 Receptor Agonist LY354740 Using a Prodrug Strategy: In Vivo Pharmacology of LY544344
Numerous studies have indicated that selective agonists of group II metabotropic glutamate (mGlu) receptors, such as LY354740… 
  • table 1
  • table 2
Review
2005
Review
2005
LY-544344. Eli Lilly.
  • W. Danysz
  • IDrugs : the investigational drugs journal
  • 2005
  • Corpus ID: 21820180
Eli Lilly and Co is developing LY-544344, a prodrug of the metabotropic glutamate receptor 2/3 agonist LY-354740, for the… 
Highly Cited
2004
Highly Cited
2004
Effects of a metabotropic glutamate2/3 receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results
RationalePreclinical findings have repeatedly shown an anxiolytic-like action of agonists at metabotropic glutamate receptors… 
  • table 1
  • table 2
  • figure 1
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE